Home » Stocks » MRVI

Maravai LifeSciences Holdings, Inc. (MRVI)

Stock Price: $29.16 USD 2.20 (8.16%)
Updated November 27, 1:00 PM EST - Market closed
After-hours: $28.95 -0.21 (-0.72%) Nov 27, 4:53 PM

Stock Price Chart

Key Info

Market Cap 7.74B
Revenue (ttm) 221.71M
Net Income (ttm) 58.37M
Shares Out 267.84M
EPS (ttm) 0.22
PE Ratio 132.55
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $29.16
Previous Close $26.96
Change ($) 2.20
Change (%) 8.16%
Day's Open 27.41
Day's Range 27.41 - 30.27
Day's Volume 5,155,393
52-Week Range 25.56 - 32.46

More Stats

Market Cap 7.74B
Enterprise Value 8.02B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 267.84M
Float 59.93M
EPS (basic) n/a
EPS (diluted) 0.22
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.75%
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio 132.55
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 34.91
PB Ratio 65.57
Revenue 221.71M
Operating Income n/a
Net Income 58.37M
Free Cash Flow n/a
Net Cash -283.26M
Net Cash / Share -1.07
Gross Margin 53.30%
Operating Margin n/a
Profit Margin 26.33%
FCF Margin n/a
ROA 2.72%
ROE -3.55%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth15.59%-
Gross Profit76.2963.07
Operating Income24.3117.38
Net Income-4.47-4.47
Shares Outstanding1,0001,000
Earnings Per Share-8,481.00-17,727.00
Operating Cash Flow24.12-0.19
Capital Expenditures-17.15-3.61
Free Cash Flow6.97-3.80
Cash & Equivalents24.7021.87
Total Debt390340
Net Cash / Debt-366-318
Book Value141144
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Maravai LifeSciences Holdings, Inc.
Country United States
Employees 390
CEO Carl W. Hull

Stock Information

Ticker Symbol MRVI
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MRVI
IPO Date November 20, 2020


Maravai LifeSciences Holdings operates as a life sciences company that provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry. The company serves biopharmaceutical companies, and other emerging biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.